Earlier awards, partnerships, and press mentions from the team building our nuclease platform.
Neoclease took first place and a $25,000 prize in the Collective Intelligence Startup Competition at FEI25 (Front End of Innovation), funding further work to accelerate our LRRK2 / Parkinson's gene-editing candidate.
Neoclease was featured in GEN, in an article covering how AI-enabled gene editing produces fewer off-target outcomes.
Neoclease was awarded a Golden Ticket from Chiesi Global Rare Diseases, granting one year of lab space at BioLabs in Boston, with access to the facilities, resources, and mentorship of its startup ecosystem.